Evidence map›Paper›PMID 37332721›Full record

ArticleFrontiers in plant science2023

The use of chitosan oligosaccharide to improve artemisinin yield in well-watered and drought-stressed plants.

Ana L García-García, Ana Rita Matos, Eduardo Feijão, Ricardo Cruz de Carvalho, Alicia Boto, Jorge Marques da Silva, David Jiménez-Arias

Open access · goldAbstract read
In one paragraph

Article in Frontiers in plant science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
6.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Effect of chitosan on plant growth, physiological traits, rhizome attributes, and curcuminoids content of turmeric (Physiology and molecular biology of plants : an international journal of functional plant biology · 2025
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Ana L García-GarcíaGrupo Síntesis de Fármacos y Compuestos Bioactivos, Departamento de Química de Productos Naturales y Sintéticos Bioactivos, Instituto de Productos Naturales y Agrobiología, Consejo Superior de Investigaciones Científicas, San Cristóbal de La Laguna, Spain.
Ana Rita MatosDepartamento de Biologia Vegetal, Faculdade de Ciências da Universidade de Lisboa, Lisbon, Portugal.
Eduardo FeijãoMARE - Marine and Environmental Sciences Centre and ARNET - Aquatic Research Infrastructure Network Associate Laboratory, Faculdade de Ciências da Universidade de Lisboa, Lisbon, Portugal.
Ricardo Cruz de CarvalhoDepartamento de Biologia Vegetal, Faculdade de Ciências da Universidade de Lisboa, Lisbon, Portugal.
Alicia BotoGrupo Síntesis de Fármacos y Compuestos Bioactivos, Departamento de Química de Productos Naturales y Sintéticos Bioactivos, Instituto de Productos Naturales y Agrobiología, Consejo Superior de Investigaciones Científicas, San Cristóbal de La Laguna, Spain.
Jorge Marques da SilvaBioISI - Biosystems and Integrative Sciences Institute, Plant Functional Genomics Group, Departamento de Biologia Vegetal, Faculdade de Ciências da Universidade de Lisboa, Lisbon, Portugal.
David Jiménez-AriasISOPlexis-Center for Sustainable Agriculture and Food Technology, Madeira University, Funchal, Portugal.
University of Lisbon · PTConsejo Superior de Investigaciones Científicas · ESUniversidad de La Laguna · ESUniversidade da Madeira · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Artemisinin is a secondary metabolite well-known for its use in the treatment of malaria. It also displays other antimicrobial activities which further increase its interest. At present, Artemisia annua is the sole commercial source of the substance, and its production is limited, leading to a global deficit in supply. Furthermore, the cultivation of A. annua is being threatened by climate change. Specifically, drought stress is a major concern for plant development and productivity, but, on the other hand, moderate stress levels can elicit the production of secondary metabolites, with a putative synergistic interaction with elicitors such as chitosan oligosaccharides (COS). Therefore, the development of strategies to increase yield has prompted much interest. With this aim, the effects on artemisinin production under drought stress and treatment with COS, as well as physiological changes in A. annua plants are presented in this study. Methods: Plants were separated into two groups, well-watered (WW) and drought-stressed (DS) plants, and in each group, four concentrations of COS were applied (0, 50,100 and 200 mg•L-1). Afterwards, water stress was imposed by withholding irrigation for 9 days. Results: Therefore, when A. annua was well watered, COS did not improve plant growth, and the upregulation of antioxidant enzymes hindered the production of artemisinin. On the other hand, during drought stress, COS treatment did not alleviate the decline in growth at any concentration tested. However, higher doses improved the water status since leaf water potential (YL) improved by 50.64% and relative water content (RWC) by 33.84% compared to DS plants without COS treatment. Moreover, the combination of COS and drought stress caused damage to the plant's antioxidant enzyme defence, particularly APX and GR, and reduced the amount of phenols and flavonoids. This resulted in increased ROS production and enhanced artemisinin content by 34.40% in DS plants treated with 200 mg•L-1 COS, compared to control plants. Conclusion: These findings underscore the critical role of ROS in artemisinin biosynthesis and suggest that COS treatment may boost artemisinin yield in crop production, even under drought conditions.

Indexed as

Artemisia annuaartemisininbioactive metaboliteschitosan oligosaccharidedroughtelicitationstress

Identifiers

PMID37332721
PMCPMC10272596
OpenAlexW4379232622

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.